BEDFORD - Hologic Inc., which makes mammogram systems and other women’s health diagnostic tools, said quarterly profit fell 32 percent. But the company said it sees early signs of stabilization in the mammogram equipment market.
Hologic said earnings for the three months ended Dec. 26 dropped to $26.1 million, or 10 cents per share, from $38.2 million, or 15 cents, in the same period last year. Excluding one-time charges, the company would have earned 29 cents per share. Revenue slipped 4 percent, to $412.4 million.
Hologic said sales of its Selenia mammography line declined as hospitals remained cautious on spending; sales of its skeletal health product line also fell.
Those drops were partially offset by increased revenue from servicing its installed mammogram systems and stronger sales of testing and surgery products.
The results topped expectations of analysts surveyed by Thomson Reuters, who had expected profit of 26 cents per share on revenue of $403.7 million.
For the fiscal second quarter, Hologic expects to earn an adjusted 29 cents per share on $410 million to $415 million in revenue.
Hologic shares closed up 18 cents at $15.25.